SEER|Seer Inc|Price:1.790|Chg%:0.04

More Details of Seer Inc Company

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.

Seer Inc Info



Ticker SymbolSEER

Company nameSeer Inc

IPO dateDec 04, 2020

CEOFarokhzad (Omid C)

Number of employees134

Security typeOrdinary Share

Fiscal year-endDec 04

Address3800 Bridge Parkway, Suite 102

CityREDWOOD CITY

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code94065

Phone16504530000

Websitehttps://seer.bio/

Ticker SymbolSEER

IPO dateDec 04, 2020

CEOFarokhzad (Omid C)

Company Executives of Seer Inc



Name

Name/Position

Position

Shareholding

Change

Mr. David L. Hallal

Independent Director

296.95K

-34735.00%

Ms. Meeta Gulyani

Independent Director

49.37K

+20500.00%

Isaac Ro

Director

41.00K

+41000.00%

Mr. Terrance G. (Terry) Mcguire

Independent Director

--

Mr. Dipchand V. (Deep) Nishar

Independent Director

--

Dr. Omid C. Farokhzad, M.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Langer (Robert S Jr)

Director

--

Mr. David R. Horn

President, Chief Financial Officer, Treasurer

--

Dr. Nicolas Henry (Nick) Roelofs, Ph.D.

Lead Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. David L. Hallal

Independent Director

296.95K

-34735.00%

Ms. Meeta Gulyani

Independent Director

49.37K

+20500.00%

Isaac Ro

Director

41.00K

+41000.00%

Mr. Terrance G. (Terry) Mcguire

Independent Director

--

Mr. Dipchand V. (Deep) Nishar

Independent Director

--

Dr. Omid C. Farokhzad, M.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2024

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United States

9.49M

67.00%

Asia and Europe

4.68M

33.00%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Aug 17

Shareholders

Shareholder Types

Shareholders

Proportion

SB Global Advisers Ltd

9.13%

aMoon Fund

8.75%

Invus Public Equities Advisors, LLC

7.11%

Farokhzad (Omid)

4.86%

The Vanguard Group, Inc.

3.89%

Other

66.25%

Shareholders

Proportion

SB Global Advisers Ltd

9.13%

aMoon Fund

8.75%

Invus Public Equities Advisors, LLC

7.11%

Farokhzad (Omid)

4.86%

The Vanguard Group, Inc.

3.89%

Other

66.25%

Shareholder Types

Shareholders

Proportion

Investment Advisor

28.43%

Venture Capital

10.28%

Investment Advisor/Hedge Fund

7.96%

Hedge Fund

7.96%

Individual Investor

6.88%

Family Office

2.54%

Research Firm

0.64%

Other

35.32%

Institutional Shareholding



Updated: Thu, Jan 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

192

31.15M

55.38%

-8.32M

2025Q3

201

32.64M

63.07%

-8.15M

2025Q2

215

34.75M

66.40%

-11.36M

2025Q1

247

35.30M

64.30%

-11.82M

2024Q4

260

37.19M

66.69%

-9.00M

2024Q3

273

37.72M

67.07%

-11.48M

2024Q2

281

43.51M

73.62%

-10.31M

2024Q1

277

47.93M

79.17%

-7.27M

2023Q4

283

47.42M

79.00%

-7.15M

2023Q3

280

48.81M

81.72%

-6.96M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

SB Global Advisers Ltd

5.14M

9.13%

--

Sep 30, 2025

aMoon Fund

4.92M

8.75%

--

Dec 31, 2024

Invus Public Equities Advisors, LLC

4.00M

7.11%

--

Sep 30, 2025

Farokhzad (Omid)

2.04M

3.63%

+1.44M

+239.18%

Dec 09, 2025

The Vanguard Group, Inc.

2.22M

3.95%

+18.76K

+0.85%

Sep 30, 2025

Acadian Asset Management LLC

2.14M

3.81%

-5.84K

-0.27%

Sep 30, 2025

Radoff Family Foundation

1.40M

2.49%

-2.86M

-67.11%

Jun 30, 2025

Tang Capital Management, LLC

1.34M

2.39%

--

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

1.17M

2.08%

-10.65K

-0.90%

Sep 30, 2025

Renaissance Technologies LLC

1.11M

1.97%

-7.41K

-0.66%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

iShares Micro-Cap ETF

0.02%

Avantis US Small Cap Equity ETF

0.01%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Dimensional US Core Equity 1 ETF

0%

ProShares Hedge Replication ETF

0%

Avantis US Equity ETF

0%

DFA Dimensional US Sustainability Core 1 ETF

0%

Schwab U.S. Small-Cap ETF

0%

iShares Russell 2000 ETF

0%

Proshares Ultra Russell 2000

0%

iShares Micro-Cap ETF

Proportion0.02%

Avantis US Small Cap Equity ETF

Proportion0.01%

Invesco RAFI US 1500 Small-Mid ETF

Proportion0.01%

Dimensional US Core Equity 1 ETF

Proportion0%

ProShares Hedge Replication ETF

Proportion0%

Avantis US Equity ETF

Proportion0%

DFA Dimensional US Sustainability Core 1 ETF

Proportion0%

Schwab U.S. Small-Cap ETF

Proportion0%

iShares Russell 2000 ETF

Proportion0%

Proshares Ultra Russell 2000

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data